Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Soleno Therapeutics Inc 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065 USA

www.soleno.life P: 650-213-8444 F: 650-213-8383

Description:

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,339,113
Enterprise Value, $K 1,169,433
Shares Outstanding, K 33,411
Annual Sales, $ 0 K
Annual Net Income, $ -38,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,400 K
EBIT, $ -56,390 K
EBITDA, $ -54,430 K
60-Month Beta -1.40
% of Insider Shareholders 12.30%
% of Institutional Shareholders 97.42%
Float, K 29,301
% Float 87.70%
Short Volume Ratio 0.54

Growth:

1-Year Return 800.67%
3-Year Return 142.91%
5-Year Return 5.20%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 75.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.59 on 05/09/24
Next Earnings Date 08/13/24
Earnings Per Share ttm -2.68
EPS Growth vs. Prev Qtr -78.79%
EPS Growth vs. Prev Year 32.95%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/26/22

SLNO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.84%
Return-on-Assets % -46.87%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.50
Book Value/Share 4.29
Interest Coverage -1.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar